Neurosterix
Jean-Laurent Paparin, PhD, is an accomplished professional in the field of chemistry with extensive experience in drug discovery and development. Currently serving as the Director and Head of Chemistry at Neurosterix since March 2024, Jean-Laurent previously held similar leadership roles at Addex Therapeutics from April 2019 to February 2024. Jean-Laurent's background includes pivotal positions such as Drug Discovery Project Coordinator at ENYO Pharma and Principal Scientist at MSD, where contributions to oncology and various therapeutic areas were made. Earlier in the career, Jean-Laurent developed expertise in synthetic organic chemistry, leading teams at Idenix Pharmaceuticals and Neuro3d, and holding scientific roles at Molecumetics Ltd. Jean-Laurent earned a PhD in Organic Synthesis from Ecole Nationale Supérieure de Chimie de Rennes and additional qualifications in synthetic organic chemistry and workplace safety.
This person is not in any teams
Neurosterix
Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators — molecules that increase or decrease the activity of target receptors by binding outside of the “active site” where endogenous ligands and traditional drugs operate. Through this platform, Neurosterix’s novel drug candidates have the potential to provide medicines with improved efficacy, safety and tolerability for patient communities suffering from underserved neurological disorders.